Founder & CEO · Converge Bio · Tel Aviv-Yafo, Tel Aviv, Israel
Fresh capital means vendor and tool decisions are happening right now.
Open roles signal budget is being allocated across the org.
Most founders lock in key vendors within 60 days of closing a round.
Converge Bio is accelerating drug development through GenAI-powered innovations in discovery, molecule design and manufacturing to create the therapies of tomorrow, today.
